These independent CME/CE activities are supported by an educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.and GlaxoSmithKline



     Pulmonology Mastery in
  COPD
  1. Course List
Chair
faculty image
Barry J. Make, MD
  • Co-Director, COPD Program
  • Division of Pulmonary and Critical Care Medicine
  • National Jewish Health
  • Denver, Colorado
  • Pulmonology Mastery in COPD is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in COPD. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the ATS (American Thoracic Society) 2017 Meeting, the ERS (European Respiratory Society) International Congress 2017, and CHEST (American College of Chest Physicians) Annual Meeting and poster presentations from CHEST (American College of Chest Physicians) Annual Meeting.
  • Describe the natural history of chronic obstructive pulmonary disease (COPD), the importance of early diagnosis of this condition, and recent advances in our understanding of pathophysiologic mechanisms that may serve as targets of therapy. 

  • Evaluate criteria that have been developed to assess treatment response in COPD, delineate how these criteria can be used to risk-stratify patients in clinical practice, and consider therapeutic treatment options that improve patient outcomes.
  • Target Audience

    Pulmonologists, respiratory specialists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other allied healthcare professionals involved in the screening and treatment of patients with COPD.

     

    Activity Goal

    The goal of this program is to provide new information based on breaking medical news, new data presented at medical meetings, and interactive cases on the most up-to-date evidence-based medicine and clinical trial results in COPD.